Sai Shankar and Chris Hogg draw upon recent research and their experiences in digital health, including interviews with payers, to explore the current state of connected medicines. They believe there are four key themes which need to be addressed to ensure the promise of connected devices is successfully met.
Publications, Pharmaceutical
Connected Medicine: Insights from Payers and Other Stakeholders
Connected medicine is widely recognized as having considerable potential to improve patient outcomes while at the same time reducing healthcare costs. This article summarizes real-life experience, recent research and discussions with payers/stakeholders across the digital healthcare ecosystem, assessing the current state of play and barriers to progress. Insights were gathered from senior representatives of healthcare plans, pharmacy benefit managers, life science manufacturers and integrated delivery networks and four keys were identified with respect to realizing the potential of connected medicine: connectivity and patient engagement; adherence; coverage; and cost and adoption challenges. The real-life experience of Propeller Health is also discussed. This company works collaboratively with Aptar Pharma and has already deployed more than 60 connected medicine programs.
Author(s):
Chris Hogg (Propeller Health)
Sai Shankar
ONdrugDelivery
1
Jun
2018
Subscribe to Email Updates
Submit your email address below and stay up to date with the latest industry insights.
*Required. For details about how your email address will be used, read our General Terms and Conditions of Use, Privacy and Cookies Policy.
Related Articles
Request Access
Close
Requesting access to Connected Medicine: Insights from Payers and Other Stakeholders.
How Can We Help?
